Guillemette E. Benoist

Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

Guillemette E. Benoist, Inge M. van Oort, Stella Smeenk et al. · British Journal of Clinical Pharmacology · 2017 · 54 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study

Guillemette E. Benoist, Inge M. van Oort, Emmy Boerrigter et al. · Clinical Chemistry · 2020 · 40 citations · Full text

Medicine, Oncology, Pharmacology +17

Analytical challenges in quantifying abiraterone with LC–MS/MS in human plasma

Guillemette E. Benoist, Eric van der Meulen, Floor J.E. Lubberman et al. · Biomedical Chromatography · 2017 · 26 citations · Full text

Pharmacy, Pharmacology, Analytical Chemistry +16

Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration–Resistant Prostate Cancer

Guillemette E. Benoist, Eric van der Meulen, Inge M. van Oort et al. · Therapeutic Drug Monitoring · 2018 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

A prospective phase I multicentre randomized cross-over pharmacokinetic study to determine the effect of food on abiraterone pharmacokinetics

Floor J.E. Lubberman, Guillemette E. Benoist, Winald R. Gerritsen et al. · Cancer Chemotherapy and Pharmacology · 2019 · 13 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14